NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization59.9 mln
Float149 mln
Earnings Date11/10/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-2.5
Borderline
Relative Strength
27
/ 100
Underperforming
Debt / Equity
21.48
Extremely leveraged
Pre-Tax Margin
-23%
Deeply loss-making
ROE
-946
Deeply negative
Business Description
Heron Therapeutics is a North Carolina-based biotech company focused on improving patient care through innovative drug delivery. Its core technology allows a single dose of medication to remain active in the body for days or even weeks, reducing how often patients need treatment. The company sells several approved products that help cancer patients manage nausea and vomiting caused by chemotherapy, and it is also developing a local anesthetic designed to provide longer-lasting pain relief after surgery.
